{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:32:41Z","timestamp":1793831561655,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.pdpdt.2024.104224","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T18:36:51Z","timestamp":1716662211000},"page":"104224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinical predictive factors and imaging biomarkers of treatment response to half dose PDT in patients with chronic central serous chorioretinopathy"],"prefix":"10.1016","volume":"48","author":[{"given":"Reza","family":"Mirshahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masood","family":"Naseripour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Ghomashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil Ghasemi","family":"Falavarjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2024.104224_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/2474126417746462","article-title":"Optical density of subretinal fluid as a predictive biomarker for eyes with chronic central serous retinopathy treated with eplerenone","volume":"2","author":"Joshi","year":"2018","journal-title":"J. Vitreoretin. Dis."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0002","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IAE.0000000000000837","article-title":"Factors for central serous chorioretinopathy","volume":"36","author":"Liu","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","article-title":"The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980\u20132002","volume":"115","author":"Kitzmann","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9394(67)90030-X","article-title":"Pathogenesis of disciform detachment of the neuroepithelium","volume":"63","author":"Donald","year":"1967","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0006","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bjo.68.11.815","article-title":"Long-term follow-up of central serous chorioretinopathy","volume":"68","author":"Gilbert","year":"1984","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0007","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1442-9071.2012.02847.x","article-title":"Diagnosis and interventions for central serous chorioretinopathy: review and update","volume":"41","author":"Quin","year":"2013","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0008","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/IAE.0b013e318156777f","article-title":"Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy","volume":"28","author":"Chan","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0009","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IAE.0b013e3181e378f2","article-title":"Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"31","author":"Shin","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4274\/tjo.galenos.2018.49035","article-title":"Current therapeutic approaches to chronic central serous chorioretinopathy","volume":"49","author":"G\u00fclka\u015f","year":"2019","journal-title":"Turk. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0011","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archopht.1994.01090200063023","article-title":"Digital indocyanine green videoangiography of central serous chorioretinopathy","volume":"112","author":"Guyer","year":"1994","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0012","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0161-6420(84)34095-7","article-title":"Retinal pigment epithelium decompensation","volume":"91","author":"Jalkh","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0013","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI115315","article-title":"Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells","volume":"88","author":"Sakaue","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0014","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","article-title":"Indocyanine green videoangiography of older patients with central serous chorioretinopathy","volume":"16","author":"Spaide","year":"1996","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0015","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/IAE.0b013e318156db8a","article-title":"The natural history of pigment epithelial detachment associated with central serous chorioretinopathy","volume":"27","author":"Mudvari","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0016","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archopht.1974.03900060257001","article-title":"Experience with nontreatment of central serous choroidopathy","volume":"91","author":"Klein","year":"1974","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-198700720-00009","article-title":"Type-A behavior and central serous chorioretinopathy","volume":"7","author":"Yannuzzi","year":"1987","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0018","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1442-9071.2005.01027.x","article-title":"Long-term macular function in eyes with central serous chorioretinopathy","volume":"33","author":"Baran","year":"2005","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0019","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/archopht.1984.01040031049021","article-title":"Visual function abnormalities in central serous retinopathy","volume":"102","author":"Folk","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0021","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","article-title":"Central serous chorioretinopathy","volume":"86","author":"Wang","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0022","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3928\/23258160-20131220-01","article-title":"Current concepts in managing central serous chorioretinopathy","volume":"45","author":"Fine","year":"2014","journal-title":"Ophthalm. Surg. Laser. Imag. Retin."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0023","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/eye.2010.130","article-title":"Central serous chorioretinopathy: an update on pathogenesis and treatment","volume":"24","author":"Gemenetzi","year":"2010","journal-title":"Eye"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0024","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ophtha.2013.11.040","article-title":"Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy","volume":"121","author":"Lim","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5301\/ejo.5000051","article-title":"Long-term results of half-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"22","author":"Rouvas","year":"2012","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2022.103107","article-title":"Prediction of the response to photodynamic therapy in patients with chronic central serous chorioretinopathy based on optical coherence tomography using deep learning","volume":"40","author":"Fern\u00e1ndez-Vigo","year":"2022","journal-title":"Photodiagnos. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0027","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/eye.2014.134","article-title":"Photodynamic therapy for central serous chorioretinopathy","volume":"28","author":"Erikitola","year":"2014","journal-title":"Eye"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0028","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/2008-322X.180706","article-title":"Half-dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"11","author":"Naseripour","year":"2016","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0029","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00417-016-3373-3","article-title":"Clinical experience with eplerenone to treat chronic central serous chorioretinopathy","volume":"254","author":"Cakir","year":"2016","journal-title":"Graefe's Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/jop.2016.0068","article-title":"Therapy rationale for mineralocorticoid-receptor antagonists, acetazolamide and a switch of therapy in nonresponders in central serous chorioretinopathy","volume":"33","author":"R\u00fcbsam","year":"2017","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0031","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.ophtha.2010.11.029","article-title":"Comparison of the diagnostic accuracies of the spectralis, cirrus, and RTVue optical coherence tomography devices in glaucoma","volume":"118","author":"Leite","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0032","series-title":"Pachychoroid Spectrum Diseases, in: Atlas Ocul. Opt. Coherence Tomogr","first-page":"177","author":"Bazvand","year":"2022"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0033","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.oret.2023.10.024","article-title":"Comparing half-dose photodynamic therapy with subthreshold micropulse laser for the treatment of central serous chorioretinopathy","volume":"8","author":"Brelen","year":"2024","journal-title":"Ophthalmol. Retin."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0034","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.oret.2018.09.003","article-title":"Mineralocorticoid receptor antagonists in central serous chorioretinopathy","volume":"3","author":"Wang","year":"2019","journal-title":"Ophthalmol. Retin."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0035","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-024-06373-5","article-title":"Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy","author":"Huang","year":"2024","journal-title":"Graefe's Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0036","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1097\/IAE.0000000000001070","article-title":"Hyperreflective foci as an independent visual outcome predictor in macular edema due to retinal vascular diseases treated with intravitreal dexamethasone or ranibizumab","volume":"36","author":"Chatziralli","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0037","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000342159","article-title":"Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration","volume":"229","author":"Coscas","year":"2013","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.pdpdt.2024.104224_bib0038","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12886-019-1168-0","article-title":"Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0039","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/1874364101509010036","article-title":"The causes of hyperreflective dots in optical coherence tomography excluding diabetic macular edema and retinal venous occlusion\u00a7\u00a7","volume":"9","author":"Turgut","year":"2015","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0040","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1167\/iovs.17-23042","article-title":"Association between soluble CD14 in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with diabetic macular edema","volume":"59","author":"Lee","year":"2018","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.pdpdt.2024.104224_bib0041","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3928\/23258160-20221115-02","article-title":"Topical dexamethasone as an adjuvant to mineralocorticoid receptor antagonists for the treatment of recalcitrant central serous chorioretinopathy","volume":"53","author":"Wong","year":"2022","journal-title":"Ophthalm. Surg. Laser. Imaging Retina"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157210002400262X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157210002400262X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:23:11Z","timestamp":1760214191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157210002400262X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":41,"alternative-id":["S157210002400262X"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104224","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical predictive factors and imaging biomarkers of treatment response to half dose PDT in patients with chronic central serous chorioretinopathy","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104224"}}